Federal funding cuts disrupt research critical to medical advancements, impacting those needing diagnoses, treatments, and cures. Read PNRI’s op-ed in The Seattle Times to learn more.
Federal funding disruptions have stalled research, delaying critical discoveries. PNRI’s leaders share why stable support matters and how we can protect scientific progress. Read our special message.
From uncovering genetic mysteries to inspiring the next generation, PNRI’s 2024 was a year of breakthroughs, collaboration, and discovery. Read the highlights!
The messages we’ve received from TEDDY families fill us with gratitude to know that participating in our research has had a positive impact.
PNRI welcomes six new trustees, bringing expertise in science, business, and advocacy to advance groundbreaking genetic research and shape a healthier future. Meet the new trustees today!
Explore the groundbreaking TEDDY Study’s 20 years of research into type 1 diabetes (T1D). Discover how genetics and the environment interact to shape T1D risk and prevention strategies.
Dr. Cláudia Carvalho and her team at PNRI are on a mission to diagnose rare diseases that have long baffled the medical community. With a focus on genetic structural variants, often undetected in standard tests, their work is pushing the boundaries of what’s possible in genetics.
PNRI’s Dr. Michael Metzger kicks off Tech Alliance’s 2024-25 Discovery Series on Friday, September 13th at Slalom Hawk Tower. Join us for this presentation!
Explore Dr. Michael Metzger’s groundbreaking research on contagious cancer in clams, uncovering insights that could revolutionize cancer treatment in humans.
Explore how two decades of diabetes research by Dr. Bill Hagopian and Michael Killian at PNRI have paved the way for groundbreaking discoveries in type 1 diabetes prevention.